Post-cancer diagnosis dietary inflammatory potential is associated with survival among women diagnosed with colorectal cancer in the Women’s Health Initiative
Dietary factors may influence colorectal cancer (CRC) survival through effects on inflammation. We examined the association between post-CRC diagnosis inflammatory potential of diet and all-cause and cancer-specific mortality in the Women’s Health Initiative.
The study included 463 postmenopausal women who developed CRC during follow-up and completed a food frequency questionnaire (FFQ), on average 1.7 years after diagnosis. Women were followed from CRC diagnosis until death, censoring, or the end of follow-up in October 2014. Energy-adjusted dietary inflammatory index (E-DII)® scores were calculated from the FFQ and dietary supplement inventory. Cox proportional hazards models were fitted to estimate multivariable-adjusted HRs and 95% confidence intervals (CIs) for all-cause, total cancer, and CRC-specific mortality with the most pro-inflammatory E-DII scores (tertile 3) as referent.
After a median 11.6 years of follow-up, 162 deaths occurred, including 77 from CRC. Lowest tertile (i.e., most anti-inflammatory) E-DII scores from diet plus supplements were associated with significantly lower all-cause mortality (HRT1vsT3 = 0.49; 95% CI 0.31–0.79) compared to the most pro-inflammatory E-DII tertile. Modest associations with total cancer mortality or CRC-specific mortality were observed, though 95% CIs included 1.
Consuming a dietary pattern and supplements with more anti-inflammatory potential after CRC diagnosis may improve overall survival among postmenopausal women.
KeywordsPost-cancer diagnosis Dietary pattern Colorectal cancer survival Cohort study Postmenopausal women
We thank the Women’s Health Initiative Investigators: Program Office (National Heart, Lung, and Blood Institute, Bethesda, Maryland): Jacques Rossouw, Shari Ludlam, Joan McGowan, Leslie Ford, and Nancy Geller. Clinical Coordinating Center (Fred Hutchinson Cancer Research Center, Seattle, WA): Garnet Anderson, Ross Prentice, Andrea LaCroix, and Charles Kooperberg. Investigators and Academic Centers (Brigham and Women’s Hospital, Harvard Medical School, Boston, MA): JoAnn E. Manson (MedStar Health Research Institute/Howard University, Washington, DC); Barbara V. Howard (Stanford Prevention Research Center, Stanford, CA); Marcia L. Stefanick (The Ohio State University, Columbus, OH); Rebecca Jackson (University of Arizona, Tucson/Phoenix, AZ); Cynthia A. Thomson (University at Buffalo, Buffalo, NY); Jean Wactawski-Wende (University of Florida, Gainesville/Jacksonville, FL); Marian Limacher (University of Iowa, Iowa City/Davenport, IA); Jennifer Robinson (University of Pittsburgh, Pittsburgh, PA); Lewis Kuller (Wake Forest University School of Medicine, Winston-Salem, NC); Sally Shumaker (University of Nevada, Reno, NV); Robert Brunner (University of Minnesota, Minneapolis, MN); Karen L. Margolis. Women’s Health Initiative Memory Study (Wake Forest University School of Medicine, Winston-Salem, NC): Mark Espeland. Additional Information: a full list of all the investigators who have contributed to Women’s Health Initiative science appears at https://www.whi.org/researchers/Documents%20%20Write%20a%20Paper/WHI%20Investigator%20Long%20List.pdf. We also thank the Women’s Health Initiative staff and the trial participants for their outstanding dedication and commitment.
Development of methodology: JRH, NS and SES. Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): BC and JO. Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): JZ, JZ, CHK and SES. Writing, review, and/or revision of the manuscript: JZ, FKT, JZ, EAM, NS, JKO, BC, CHK, JRH and SES. Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): JZ, FKT and SES. Study supervision: SES.
J Zheng, FK Tabung, J Zhang, JK Ockene, JR Hébert, and SE Steck were supported by Grant #318258 from the American Institute for Cancer Research. J Zheng was supported by Cancer Prevention & Research Institute of Texas Grant PR170259. FK Tabung was supported by National Cancer Institute grant # K99CA207736. N Shivappa and JR Hébert were supported by Grant number R44 DK103377 from the National Institute of Diabetes and Digestive and Kidney Diseases. The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through Contracts HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C.
Compliance with ethical standards
Conflict of interest
Dr. Hébert owns controlling interest in Connecting Health Innovations, LLC (CHI), a company planning to license the right to his invention of the dietary inflammatory index (DII®) from the University of South Carolina to develop computer and smart phone applications for patient counseling and dietary intervention in clinical settings. Dr. Nitin Shivappa is an employee of CHI.
The WHI protocol was approved by the Institutional Review Boards at the Clinical Coordinating Center (CCC) at the Fred Hutchinson Cancer Research Center (Seattle, WA) and at each of the participating Clinical Centers, and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participants provided written informed consent in accordance with the US Common Rule. This study was also approved as exempt category from the Institutional Review Boards at the University of South Carolina where the study was conducted.
- 2.American Cancer Society. Cancer treatment & survivorship facts & figures, 2016–2017Google Scholar
- 5.Ratjen I, Schafmayer C, di Giuseppe R, Waniek S, Plachta-Danielzik S, Koch M, Nöthlings U, Hampe J, Schlesinger S, Lieb W (2017) Postdiagnostic Mediterranean and healthy nordic dietary patterns are inversely associated with all-cause mortality in long-term colorectal cancer survivors. J Nutr 147(4):636–644CrossRefGoogle Scholar
- 6.World Cancer Research Fund/American Institute for Cancer Research (2018) Diet, nutrition, physical activity, and cancer: a global perspective. Third expert report. AICR, Washington, DCGoogle Scholar
- 11.Crozier JE, McKee RF, McArdle CS, Angerson WJ, Anderson JH, Horgan PG, McMillan DC (2006) The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer. Br J Cancer 94(12):1833–1836. https://doi.org/10.1038/sj.bjc.6603185 CrossRefGoogle Scholar
- 13.Tabung FK, Steck SE, Ma Y, Liese AD, Zhang J, Caan B, Hou L, Johnson KC, Mossavar-Rahmani Y, Shivappa N, Wactawski-Wende J, Ockene JK, Hebert JR (2015) The association between dietary inflammatory index and risk of colorectal cancer among postmenopausal women: results from the Women’s Health Initiative. Cancer Causes Control 26(3):399–408. https://doi.org/10.1007/s10552-014-0515-y CrossRefGoogle Scholar
- 16.Wirth MD, Shivappa N, Steck SE, Hurley TG, Hebert JR (2015) The dietary inflammatory index is associated with colorectal cancer in the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Br J Nutr 113(11):1819–1827. https://doi.org/10.1017/s000711451500104x CrossRefGoogle Scholar
- 17.Harmon BE, Wirth MD, Boushey CJ, Wilkens LR, Draluck E, Shivappa N, Steck SE, Hofseth L, Haiman CA, Le Marchand L, Hébert JR (2017) The dietary inflammatory index is associated with colorectal cancer risk in the multiethnic Cohort 1–3. J Nutr 147(3):430–438. https://doi.org/10.3945/jn.116.242529 Google Scholar
- 18.Shivappa N, Hebert JR, Steck SE, Hofseth LJ, Shehadah I, Bani-Hani KE, Al-Jaberi T, Al-Nusairr M, Heath D, Tayyem R (2017) Dietary inflammatory index and odds of colorectal cancer in a case-control study from Jordan. Appl Physiol Nutr Metab 42(7):744–749. https://doi.org/10.1139/apnm-2017-0035 CrossRefGoogle Scholar
- 19.Tabung FK, Steck SE, Ma Y, Liese AD, Zhang J, Lane DS, Ho GYF, Hou L, Snetselaar L, Ockene JK, Hebert JR (2017) Changes in the inflammatory potential of diet over time and risk of colorectal cancer in postmenopausal women. Am J Epidemiol 186(5):514–523. https://doi.org/10.1093/aje/kwx115 CrossRefGoogle Scholar
- 20.Ratjen I, Shivappa N, Schafmayer C, Burmeister G, Nothlings U, Hampe J, Hebert JR, Lieb W, Schlesinger S (2019) Association between the dietary inflammatory index and all-cause mortality in colorectal cancer long-term survivors. Int J Cancer 144(6):1292–1301. https://doi.org/10.1002/ijc.31919 CrossRefGoogle Scholar
- 26.Schakel S, Sievert Y, Buzzard I (1988) Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc 88(10):1268–1271Google Scholar
- 27.Patterson RE, Kristal A, Rodabough R, Caan B, Lillington L, Mossavar-Rahmani Y, Simon MS, Snetselaar L, van Horn L (2003) Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women’s Health Initiative. J Am Diet Assoc 103(4):454–460Google Scholar
- 32.George SM, Ballard-Barbash R, Shikany JM, Caan BJ, Freudenheim JL, Kroenke CH, Vitolins MZ, Beresford SA, Neuhouser ML (2014) Better postdiagnosis diet quality is associated with reduced risk of death among postmenopausal women with invasive breast cancer in the Women’s Health Initiative. Cancer Epidemiol Biomark Prev 23(4):575–583CrossRefGoogle Scholar
- 33.Irwin ML, McTiernan A, Manson JE, Thomson CA, Sternfeld B, Stefanick ML, Wactawski-Wende J, Craft L, Lane D, Martin LW, Chlebowski R (2011) Physical activity and survival in postmenopausal women with breast cancer: results from the Women’s Health Initiative. Cancer Prev Res (Philadelphia, Pa) 4(4):522–529. https://doi.org/10.1158/1940-6207.capr-10-0295 CrossRefGoogle Scholar
- 36.Fritz A, Ries L (1998) The SEER Program code manual. National Cancer Institute, Bethesda (United States Cancer Statistics: 2004 incidence and mortality)Google Scholar
- 37.Coghill AE, Phipps AI, Bavry AA, Wactawski-Wende J, Lane DS, LaCroix A, Newcomb PA (2012) The association between NSAID use and colorectal cancer mortality: results from the Women’s Health Initiative. Cancer Epidemiol Biomark Prev 21(11):1966–1973. https://doi.org/10.1158/1055-9965.epi-12-0672 CrossRefGoogle Scholar
- 38.Zheng J, Tabung FK, Zhang J, Liese AD, Shivappa N, Ockene JK, Caan B, Kroenke CH, Hebert JR, Steck SE (2018) Association between post-cancer diagnosis dietary inflammatory potential and mortality among invasive breast cancer survivors in the Women’s Health Initiative. Cancer Epidemiol Biomark Prev 27(4):454–463. https://doi.org/10.1158/1055-9965.epi-17-0569 CrossRefGoogle Scholar
- 47.Meyerhardt JA, Sato K, Niedzwiecki D, Ye C, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Wigler DS, Venook A, Fuchs CS (2012) Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst 104(22):1702–1711. https://doi.org/10.1093/jnci/djs399 CrossRefGoogle Scholar
- 48.Yuan C, Bao Y, Sato K, Nimptsch K, Song M, Brand-Miller JC, Morales-Oyarvide V, Zoltick ES, Keum N, Wolpin BM, Meyerhardt JA, Chan AT, Willett WC, Stampfer MJ, Wu K, Giovannucci EL, Fuchs CS, Ng K (2017) Influence of dietary insulin scores on survival in colorectal cancer patients. Br J Cancer 117(7):1079–1087. https://doi.org/10.1038/bjc.2017.272 CrossRefGoogle Scholar
- 50.Schwingshackl L, Boeing H, Stelmach-Mardas M, Gottschald M, Dietrich S, Hoffmann G, Chaimani A (2017) Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a systematic review and meta-analysis of primary prevention trials. Adv Nutr 8(1):27–39. https://doi.org/10.3945/an.116.013516 CrossRefGoogle Scholar
- 51.Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE (2012) Multivitamins in the prevention of cancer in men: the Physicians’ Health Study II randomized controlled trial. JAMA 308(18):1871–1880. https://doi.org/10.1001/jama.2012.14641 CrossRefGoogle Scholar
- 52.Wassertheil-Smoller S, McGinn AP, Budrys N, Chlebowski R, Ho GY, Johnson KC, Lane DS, Li W, Neuhouser ML, Saquib J, Shikany JM, Song Y, Thomson C (2013) Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the Women’s Health Initiative. Breast Cancer Res Treat 141(3):495–505. https://doi.org/10.1007/s10549-013-2712-x CrossRefGoogle Scholar
- 53.Kwan ML, Greenlee H, Lee VS, Castillo A, Gunderson EP, Habel LA, Kushi LH, Sweeney C, Tam EK, Caan BJ (2011) Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat 130(1):195–205. https://doi.org/10.1007/s10549-011-1557-4 CrossRefGoogle Scholar
- 54.Neuhouser ML, Wassertheil-Smoller S, Thomson C, Aragaki A, Anderson GL, Manson JE, Patterson RE, Rohan TE, van Horn L, Shikany JM, Thomas A, LaCroix A, Prentice RL (2009) Multivitamin use and risk of cancer and cardiovascular disease in the Women’s Health Initiative cohorts. Arch Intern Med 169(3):294–304. https://doi.org/10.1001/archinternmed.2008.540 CrossRefGoogle Scholar
- 55.Holmes RS, Zheng Y, Baron JA, Li L, McKeown-Eyssen G, Newcomb PA, Stern MC, Haile RW, Grady WM, Potter JD, Le Marchand L, Campbell PT, Figueiredo JC, Limburg PJ, Jenkins MA, Hopper JL, Ulrich CM, Colon Cancer Family R (2010) Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry. Cancer Epidemiol Biomark Prev 19(8):2023–2034. https://doi.org/10.1158/1055-9965.EPI-09-1097 CrossRefGoogle Scholar
- 56.Lewis CM, Wolf WA, Xun P, Sandler RS, He K (2016) Racial differences in dietary changes and quality of life after a colorectal cancer diagnosis: a follow-up of the Study of Outcomes in Colorectal Cancer Survivors cohort. Am J Clin Nutr 103(6):1523–1530. https://doi.org/10.3945/ajcn.115.126276 CrossRefGoogle Scholar
- 57.Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA, Eheman CR, Ward EM (2014) Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120(9):1290–1314. https://doi.org/10.1002/cncr.28509 CrossRefGoogle Scholar
- 61.Ogino S, Kirkner GJ, Nosho K, Irahara N, Kure S, Shima K, Hazra A, Chan AT, Dehari R, Giovannucci EL, Fuchs CS (2008) Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer. Clin Cancer Res 14(24):8221–8227. https://doi.org/10.1158/1078-0432.ccr-08-1841 CrossRefGoogle Scholar
- 64.Leung EY, Crozier JE, Talwar D, O’Reilly DS, McKee RF, Horgan PG, McMillan DC (2008) Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int J Cancer 123(10):2460–2464. https://doi.org/10.1002/ijc.23811 CrossRefGoogle Scholar
- 65.Tabung FK, Steck SE, Zhang J, Ma Y, Liese AD, Tylavsky FA, Vitolins MZ, Ockene JK, Hebert JR (2016) Longitudinal changes in the dietary inflammatory index: an assessment of the inflammatory potential of diet over time in postmenopausal women. Eur J Clin Nutr 70(12):1374–1380. https://doi.org/10.1038/ejcn.2016.116 CrossRefGoogle Scholar
- 66.Neuhouser ML, Tinker L, Shaw PA, Schoeller D, Bingham SA, Horn LV, Beresford SA, Caan B, Thomson C, Satterfield S, Kuller L, Heiss G, Smit E, Sarto G, Ockene J, Stefanick ML, Assaf A, Runswick S, Prentice RL (2008) Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women’s Health Initiative. Am J Epidemiol 167(10):1247–1259. https://doi.org/10.1093/aje/kwn026 CrossRefGoogle Scholar
- 67.Tabung FK, Steck SE, Liese AD, Zhang J, Ma Y, Caan B, Chlebowski RT, Freudenheim JL, Hou L, Mossavar-Rahmani Y, Shivappa N, Vitolins MZ, Wactawski-Wende J, Ockene JK, Hebert JR (2016) Association between dietary inflammatory potential and breast cancer incidence and death: results from the Women’s Health Initiative. Br J Cancer 114(11):1277–1285. https://doi.org/10.1038/bjc.2016.98 CrossRefGoogle Scholar